内容摘要：While only 5% of Australia's exports go to the US (China is by far Australia's biggest trading partner), the US still dominates the conversation here.

While only 5% of Australia's exports go to the US (China is by far Australia's biggest trading partner), the US still dominates the conversation here.

Jeannie is one of about 1,000 people who can’t access a treatment that could extend their lives because it has not been approved for funding on the NHS in England, Wales and Northern Ireland.The drug, called Enhertu, can give patients with a specific type of incurable breast cancer an extra six months to live on average.

The health assessment body, NICE, is the only organisation around the world so far to say no to the drug for this condition. It says that it is too expensive for the NHS to fund.The decision applies in England - but Wales and Northern Ireland will follow this guidance too.Drug companies and charities have criticised NICE's decision.

Claire Rowney, chief executive of charity Breast Cancer Now, says it is "deeply unjust that patients are currently caught in a stand-off between NICE and the pharmaceutical companies”.Jeannie echoes these thoughts. “I want to stay alive, I want to keep living,” she says.

"I'm really, really annoyed and upset that NICE doesn't think my life is important enough to extend."

She says Enhertu would give her extra time with her family - and possibly keep her alive until another new treatment comes along."Domestic abuse has been kind of secretive," she added.

"Having something like a store on the side of the road right in the middle of Trowbridge, this is incredible."What we find is no-one looks at the mirror and thinks: 'I'm the victim of domestic abuse'.

"The more we build awareness, and family and colleagues are aware of the symptoms, we can all recognise them in each other."Ms Marshall added that the sanctuary was a big part of the new setup.